In this issue:
Efficacy of cilta-cel in R/R myeloma
GVHD after post-alloHCT CD19 CAR-T therapy
Safety and efficacy of JCAR021 CD19 CAR-T therapy
Role of extranodal disease sites
AKI after CAR-T therapy
Long-term cognitive impacts of CAR-T
TPO-RAs for post-CAR-T thrombocytopenia
CAR-T barriers to deprived populations in the UK
CD22 CAR-T for B-ALL relapse post-CD19 therapy
Negative effects of prior chemotherapy exposure on T-cells
Please login below to download this issue (PDF)